Início › Câncer de Mama › Texas › Austin
Ensaios clínicos de Câncer de Mama em Austin, TX
18 estudos para Câncer de Mama estão buscando participantes em locais em Austin e arredores (num raio de aproximadamente 30 milhas). Abra um estudo para ver quem pode participar e como contatar a equipe.
Texto oficial do estudo (Inglês)
Recrutando participantes para um estudo? Destaque-o no topo desta página — $99 por 30 dias →
The Evaluation of PC14586 in Patients With Advanced Solid Tumors Harboring a TP53 Y220C Mutation (PYNNACLE)
RecrutandoFase 1/2
- New Experimental Therapeutics - NEXT Oncology, Austin
An Investigational Study of BG-75202 Alone and in Combination With Other Therapeutic Agents in Adults With Advanced Solid Tumors
RecrutandoFase 1
- Next Oncology Austin, Austin
A Phase 1/1b Study of IAM1363 in HER2 Cancers
RecrutandoFase 1
- NEXT Oncology - Austin, Austin
Study of AMXT 1501 and DFMO in Combination With Standard Therapies in Advanced Solid Tumors
RecrutandoFase 1/2
- Texas Oncology, Austin
Phase 3 Study of RLY-2608 + Fulvestrant vs Capivasertib + Fulvestrant as Treatment for Locally Advanced or Metastatic PIK3CA-mutant HR+/HER2- Breast Cancer
RecrutandoFase 3
- Texas Oncology Central/South, Austin
A Study of Mutant Selective-Inhibitor (CGT6297), in Patients With Advanced Solid Tumors
RecrutandoFase 1
- NEXT Austin, Austin
A Study of Izalontamab Brengitecan Versus Chemotherapy in Participants With Previously Untreated, Locally Advanced, Recurrent Inoperable, or Metastatic Triple-negative Breast Cancer Ineligible for Anti-PD(L)1 Drugs (IZABRIGHT-Breast01)
RecrutandoFase 2/3
- Texas Oncology - Central/South Texas, Austin
Phase 3 Study to Evaluate the Efficacy and Safety of HER2/Neu Peptide GLSI-100 (GP2 + GM-CSF) in HER2/Neu Positive Subjects
RecrutandoFase 3
- Texas Oncology - Austin, Austin
Rinatabart Sesutecan (Rina-S, PRO1184, GEN1184) for Advanced Solid Tumors (GCT1184-01/ PRO1184-001)
RecrutandoFase 1/2
- Texas Oncology - Central / South Texas, Austin
Sapanisertib and Serabelisib (PIKTOR) in Various Combinations in Patients With HR+/HER2- Advanced/Metastatic Breast Cancer
RecrutandoFase 1/2
- Texas Oncology - Central/South, Austin
Cancer Pain Management Using a Web-based Intervention
Recrutando
- The University of Texas at Austin, Austin
A Study to Learn About the Study Medicine Called PF-07248144 in Combination With Fulvestrant in People With HR-positive, HER2-negative Advanced or Metastatic Breast Cancer Who Progressed After a Prior Line of Treatment.
RecrutandoFase 3
- Texas Oncology - Central South (Balcones Dr), Austin
- Texas Oncology - Central South (James Casey), Austin
Phase I Study of SYS6043 in Patients With Advanced/Metastatic Solid Tumors
RecrutandoFase 1
- NEXT Oncology Austin, Austin
cfDNA Assay Prospective Observational Validation for Early Cancer Detection and Minimal Residual Disease
RecrutandoEstudo observacionalVoluntários saudáveis bem-vindos
- Elligo Health Research, Inc., Austin
Sample Collection for Ongoing Research and Product Evaluation Study
RecrutandoEstudo observacional
- Natera, Inc., Austin
A Phase 1 Study of XL309 (ISM3091) Alone and in Combination in Participants With Advanced Solid Tumors
RecrutandoFase 1
- Exelixis Clinical Site #4, Austin
MammaPrint, BluePrint, and Full-genome Data Linked With Clinical Data to Evaluate New Gene EXpression Profiles
RecrutandoEstudo observacional
- Texas Oncology - Austin, Austin
A Phase 2 Study of PCS6422 With Capecitabine in Patients With Advanced or Metastatic Breast Cancer
RecrutandoFase 2
- Texas Oncology PA (Austin), Austin
Ensaios de Câncer de Mama em outras cidades
- New York City, NY134 estudos
- Houston, TX126 estudos
- Boston, MA111 estudos
- Nashville, TN80 estudos
- Los Angeles, CA72 estudos
- Edison, NJ68 estudos
- St. Louis, MO64 estudos
- Durham, NC63 estudos
- Queens, NY63 estudos
- Chicago, IL58 estudos
- Philadelphia, PA56 estudos
- Dallas, TX55 estudos
Outros estudos em Austin
- Câncer de Pulmão de Não Pequenas Células30 estudos
- Câncer (todos os tipos)20 estudos
- Obesidade20 estudos
- Câncer Metastático19 estudos
- Câncer Colorretal19 estudos
- Insuficiência Cardíaca18 estudos
- Sobrepeso18 estudos
- Câncer de Ovário17 estudos
- Câncer Endometrial15 estudos
- Câncer de Próstata15 estudos
- Depressão14 estudos
- Câncer de Mama Triplo-Negativo13 estudos
Fonte: ClinicalTrials.gov, dados obtidos em 5 de out. de 2026. Cada estudo define seus próprios critérios de elegibilidade; a equipe do estudo decide quem pode participar.